SCHEMBL20161244

SCHEMBL20161244

C=Cc1cc(C)ccc1NCC

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.38
TSHR P16473 1/20 0.38
RECQL P46063 1/20 0.38
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
ALDH1A1 P00352 3/20 0.35
TP53 P04637 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
SMN1; SMN2 Q16637 3/20 0.34
HTT P42858 3/20 0.33
MAPT P10636 2/20 0.33
HTR1A P08908 2/20 0.33
ADRA1D P25100 2/20 0.33
ADRA1A P35348 2/20 0.33
ADRA1B P35368 2/20 0.33
HPGD P15428 2/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
KDM4E B2RXH2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29295039 0.85 TSHR (0.38) CYP3A4TSHRRECQLCYP1A2CYP2C9
SCHEMBL21323393 0.83 UTS2R (0.43) CYP3A4CYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL22073753 0.81 ALDH1A1 (0.38) CYP3A4TSHRRECQLCYP1A2CYP2C9
SCHEMBL25660805 0.80 CYP3A4 (0.53) CYP3A4TSHRRECQLCYP1A2CYP2C9
SCHEMBL14100633 0.79 TDP1 (0.38) RECQLCYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL24928429 0.78 HTT (0.49) CYP3A4CYP1A2CYP2C9CYP2C19SMN1; SMN2
SCHEMBL19432185 0.77 TDP1 (0.36) CYP1A2CYP2C9CYP2C19ALDH1A1TP53
SCHEMBL14201368 0.77 TDP1 (0.36) CYP3A4CYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL29264552 0.76 METAP2 (0.37) CYP3A4TSHRRECQLALDH1A1TDP1
SCHEMBL7776231 0.75 ALDH1A1 (0.40) CYP3A4TSHRRECQLCYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018089199-A1 OXAZOLE DERIVATIVES FOR USE AS IRAK INHIBITORS AND METHOD FOR THEIR PREPARATION RIGEL PHARMACEUTICALS, INC. (US) 2018-05-17 WO disclosed